Table 2 HPV prevalence ratios by age strata and carcinogenic risk
From: Age-specific prevalence of human papilloma virus infection among Nigerian women
HPV Types | Age strata (Years) | P for Trend | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
≤ 30 | 31 - 35 | 36 - 40 | 41 - 45 | > 45 | |||||||
N | PR (95% CI) | N | PR (95% CI) | N | PR (95% CI) | N | PR (95% CI) | N | Ref | ||
Any HPV (n = 136) | 49 | 2.26 (1.17, 4.34) | 40 | 1.88 (0.96, 3.67) | 24 | 1.54 (0.76, 3.10) | 14 | 1.02 (0.47, 2.20) | 9 | 1.00 | 0.0003 |
Multiple HPV (n = 46) | 16 | 4.38 (1.07, 17.94) | 18 | 5.00 (1.23, 20.30) | 7 | 2.15 (0.47, 9.77) | 3 | 0.94 (0.16, 5.33) | 2 | 1.00 | 0.0004 |
Group 1 (n = 61) | 21 | 3.83 (1.23, 11.94) | 17 | 3.15 (0.99, 10.00) | 12 | 2.46 (0.74, 8.10) | 8 | 1.67 (0.47, 5.86) | 3 | 1.00 | 0.0014 |
Group 2* (n = 75) | 28 | 2.19 (0.99, 4.84) | 23 | 1.85 (0.82, 4.18) | 12 | 1.13 (0.46, 2.77) | 6 | 0.62 (0.22, 1.79) | 6 | 1.00 | 0.0007 |